Early research (Phase 1)Ended earlyNCT02295501
What this trial is testing
A Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Disease Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus Disease
Who this might be right for
Acute Ebola Virus Disease
Cerus Corporation 6